Necesidades por zona
Elija su zona problemática
Contorno y pómulos
Efectos del envejecimiento
Disminución de las bolsas de grasa de las mejillas y pérdida de volumen debidas a la gravedad3,5,12
Problema específico
Pliegues visibles entre las decrecientes bolsas de grasa,2 que crean un aspecto cansado, resentido y triste6
Expectativas del tratamiento estético
Aporta definición y esculpe las formas para conseguir una apariencia más hermosa y joven2,3,6
No hinchazón antiestética (aspecto de ardilla) en el rostro6
Relleno natural y efecto lifting6
Resultados duraderos7 con efectos secundarios mínimos7,8
Tratamiento
TEOSYAL® PURESENSE ULTRA DEEP9
Mejillas
Efectos del envejecimiento
Pérdida de la grasa subyacente, redistribución de la grasa3,12
Problema específico
El hundimiento, los pliegues y las depresiones crean un aspecto desgastado2,6
Expectativas del tratamiento estético
Relleno de la zona hundida y rejuvenecimiento de la apariencia2,3
Conservación del dinamismo facial6
Efectos de lifting natural y resultados duraderos7 con efectos secundarios mínimos7,8
Tratamiento
TEOSYAL RHA® 411
Pliegues nasolabiales
Efectos del envejecimiento
Pérdida de la grasa subyacente, elasticidad de la piel y movimientos musculares repetidos2,4,6
Problema específico
Asimetrías, pliegues profundos y piel caída que crea un aspecto triste y cansado2,6
Expectativas del tratamiento estético
Desaparición de las asimetrías y reafirmación de la piel, relleno de pliegues pronunciados2 Conservación del dinamismo facial (no aspecto inexpresivo)6 Rejuvenecimiento natural6,7 Resultados duraderos7 con efectos secundarios mínimos7,8
Tratamiento
TEOSYAL RHA® 310
Referencias
TEOSYAL RHA® 3, TEOSYAL RHA® 4 and TEOSYAL® PURESENSE ULTRA DEEP are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local anesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents, we recommend not use lidocaine-containing products and please refer to products without lidocaine. TEOSYAL® PURESENSE Ultra Deep exist also without lidocaine : TEOSYAL® ULTRA DEEP. They are class III medical device and are regulated health product bearing the CE marking (CE2797) under this regulation.
Local manifestations: inflammatory reactions (erythema, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, dyschromia, abscesses, indurations, nodules (possibly granulomas).
General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant.
Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke.
Please consult your physician or pharmacist for more information.
Please refer to instructions for use. The product availability depends on registration, please contact your local distributor. Please inform the manufacturer TEOXANE of any side effects or any claim as soon as possible to the following address: medical@teoxane.com.
- Emre IE, Cakmak O. Ageing face, an overview – Aetiology, assessment and management. Otorhinolaryngol. 2013;6(3):160-6.
- Bass LS. Injectable filler techniques for facial rejuvenation, volumization, and augmentation. Facial Plast Surg Clin North Am. 2015;23(4):479-88.
- Gutowski KA. Hyaluronic acid fillers: science and clinical uses. Clin Plast Surg. 2016;43(3):489-96.
- Coleman SR, Grover R. The anatomy of the aging face: volume loss and changes in 3-dimensional topography. Aesthet Surg J. 2006;26(1S):S4-9.
- Pao KY, Mancini R. Nonsurgical periocular rejuvenation: advanced cosmetic uses of neuromodulators and fillers. Curr Opin Ophthalmol. 2014;25(5):461-9.
- Michaud T, Gassia V, Belhaouari L. Facial dynamics and emotional expressions in facial aging treatments. J Cosmet Dermatol. 2015;14(1):9-21.
- Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clin Interv Aging. 2007;2(3):369-76
- TEOXANE DoF 207414-E_ADV-TEOSYAL_UK.pdf (page 56, reference 3: TEOXANE International study 2017)
- TEOXANE Data on File. TEOSYAL® PURESENSE ULTRA DEEP Notice
- TEOXANE Data on File.Teosyal RHA® 3 Notice.
- TEOXANE Data on File.Teosyal RHA® 4 Notice.
- Luthra A. Shaping lips with fillers. J Cutan Aesthet Surg. 2015;8(3):139-42.
